Safer Conception for Women - Understanding Use of Periconception PrEP

PHASE4CompletedINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

November 13, 2017

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
HIV PreventionConception
Interventions
BEHAVIORAL

PrEP for Safer Conception

Evaluation of uptake of and adherence to PrEP and safer conception strategies including: CHCT, ART for the infected partner, and uptake of contraception for those who decide not to conceive by enrolled women, during periconception and pregnancy follow up.

Trial Locations (1)

4001

Maternal, Adolescent, and Child Health Research Unit (MRU), Durban

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

University of Witwatersrand, South Africa

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Massachusetts General Hospital

OTHER

NCT03194308 - Safer Conception for Women - Understanding Use of Periconception PrEP | Biotech Hunter | Biotech Hunter